APMA Comments to CMS on NCD for Autologous Blood-Derived Products for Chronic Non-Healing Wounds | News | APMA
APMA Comments to CMS on NCD for Autologous Blood-Derived Products for Chronic Non-Healing Wounds

APMA Comments to CMS on NCD for Autologous Blood-Derived Products for Chronic Non-Healing Wounds Members Only Content

APMA recommended deleting the language in the NCD stating autologous PRP is non-covered when used for the treatment of “chronic, non-healing, cutaneous wounds.”

This content is available to APMA members only. If you are a member, please log in to see the full content.



Related Resources

New CPT® Code Set Effective January 1, 2023

Learn More

2023 MIPS Webinar Series—Register Today

Learn More

ADVERTISEMENT
Be an advocate for your profession in five minutes or less. Log on today.